BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 6092953)

  • 1. Lymphadenopathy-associated viral antibody in AIDS. Immune correlations and definition of a carrier state.
    Laurence J; Brun-Vezinet F; Schutzer SE; Rouzioux C; Klatzmann D; Barré-Sinoussi F; Chermann JC; Montagnier L
    N Engl J Med; 1984 Nov; 311(20):1269-73. PubMed ID: 6092953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
    Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC
    J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Kaposi sarcoma in acquired immune deficiency syndrome (AIDS). I: Clinical findings and laboratory diagnosis].
    Weidauer H; Hofmann H
    Laryngol Rhinol Otol (Stuttg); 1985 Aug; 64(8):418-22. PubMed ID: 2995739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphadenopathic type of Kaposi's sarcoma in a Ugandan child seropositive for LAV/HTLV-III antibodies.
    Marquart KH; Müller HA; Hartter P; Oku JC; Ayuko WO
    J Trop Med Hyg; 1987 Apr; 90(2):93-4. PubMed ID: 3470530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of the AIDS epidemic.
    Evatt BL; Gomperts ED; McDougal JS; Ramsey RB
    N Engl J Med; 1985 Feb; 312(8):483-6. PubMed ID: 2982095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precipitable immune complexes in healthy homosexual men, acquired immune deficiency syndrome and the related lymphadenopathy syndrome.
    Euler HH; Kern P; Löffler H; Dietrich M
    Clin Exp Immunol; 1985 Feb; 59(2):267-75. PubMed ID: 3156700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T-cell lymphotropic virus type III associated disorders. The spectrum in the heterosexual population.
    Gill PS; Levine AM; Meyer PR; Aguilar SL; Rarick M; Parker JW; Rasheed S
    Arch Intern Med; 1986 Aug; 146(8):1501-4. PubMed ID: 3015064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS.
    Tenner-Racz K; Racz P; Bofill M; Schulz-Meyer A; Dietrich M; Kern P; Weber J; Pinching AJ; Veronese-Dimarzo F; Popovic M
    Am J Pathol; 1986 Apr; 123(1):9-15. PubMed ID: 3008562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of HTLV-III seropositivity and lymphadenopathy.
    Jeffries E; Boyko WJ; Willoughby B; Constance PD; Wiggs B; O'Shaughnessy M; Sharp FR
    Can Med Assoc J; 1985 Jul; 133(2):111-2. PubMed ID: 2988732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Vancouver Lymphadenopathy-AIDS Study: 3. Relation of HTLV-III seropositivity, immune status and lymphadenopathy.
    Boyko WJ; Schechter MT; Jeffries E; Douglas B; Maynard M; O'Shaughnessy M
    Can Med Assoc J; 1985 Jul; 133(1):28-32. PubMed ID: 2988730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
    Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
    J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome.
    Brun-Vezinet F; Rouzioux C; Barre-Sinoussi F; Klatzmann D; Saimot AG; Rozenbaum W; Christol D; Gluckmann JC; Montagnier L; Chermann JC
    Lancet; 1984 Jun; 1(8389):1253-6. PubMed ID: 6144973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men.
    Polk BF; Fox R; Brookmeyer R; Kanchanaraksa S; Kaslow R; Visscher B; Rinaldo C; Phair J
    N Engl J Med; 1987 Jan; 316(2):61-6. PubMed ID: 3024007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type III (LAV/HTLV) in a population of homosexuals in Mexico].
    Sierra Madero JG; Ponce de León S; Ruiz Palacios G; Tinoco JC; Calva JJ; Zamora EE
    Salud Publica Mex; 1986; 28(2):180-5. PubMed ID: 3014666
    [No Abstract]   [Full Text] [Related]  

  • 16. Kaposi's sarcoma and HTLV-III: a study in Nigerian adult males.
    Otu AA
    J R Soc Med; 1986 Sep; 79(9):510-4. PubMed ID: 3021963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasis.
    Friedland GH; Saltzman BR; Rogers MF; Kahl PA; Lesser ML; Mayers MM; Klein RS
    N Engl J Med; 1986 Feb; 314(6):344-9. PubMed ID: 3456076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibodies against human T-cell leukemia virus type III in acquired immunodeficiency syndrome and persistent lymphadenopathy].
    Wernicke D; v d Helm K; Abb J; Eberle J; Zoulek G; Pleyl G; Deinhardt F; Riethmüller G; Ziegler-Heitbrock HW; Rieber EP
    Dtsch Med Wochenschr; 1984 Nov; 109(45):1709-11. PubMed ID: 6094134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered excretion of modified nucleosides and beta-aminoisobutyric acid in subjects with acquired immunodeficiency syndrome or at risk for acquired immunodeficiency syndrome.
    Borek E; Sharma OK; Buschman FL; Cohn DL; Penley KA; Judson FN; Dobozin BS; Horsburgh CR; Kirkpatrick CH
    Cancer Res; 1986 May; 46(5):2557-61. PubMed ID: 3008993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphadenopathy associated virus and its etiological role in AIDS.
    Montagnier L; Chermann JC; Barré-Sinoussi F; Klatzmann D; Wain-Hobson S; Alizon M; Clavel F; Brun-Vezinet F; Vilmer E; Rouzioux C
    Princess Takamatsu Symp; 1984; 15():319-31. PubMed ID: 6100650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.